Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19

BACKGROUND: Neutralizing monoclonal antibodies (MAbs) are a promising therapy for early coronavirus disease 2019 (COVID-19), but their effectiveness has not been confirmed in a real-world setting. METHODS: In this quasi-experimental pre-/postimplementation study, we estimated the effectiveness of MA...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Open Forum Infect Dis
Κύριοι συγγραφείς: Webb, Brandon J, Buckel, Whitney, Vento, Todd, Butler, Allison M, Grisel, Nancy, Brown, Samuel M, Peltan, Ithan D, Spivak, Emily S, Shah, Mark, Sakata, Theadora, Wallin, Anthony, Stenehjem, Eddie, Poulsen, Greg, Bledsoe, Joseph
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2021
Θέματα:
Major Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314951/
https://ncbi.nlm.nih.gov/pubmed/34327256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab331
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια